Across TCGA pan-cancer cohorts, H2AC15 Mutation is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated H2AC15 data layer compared with 1 for mass-spec protein.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher H2AC15 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated H2AC15 expression acts as an unfavorable survival marker.
SKCM are the cancer types where H2AC15 Mutation most reproducibly stratifies survival.